This course will address the science of psychedelic drugs, their action in the brain and their therapeutic application and action in mental healthcare. It will review scientific research involving human brain imaging as well as clinical trials of psychedelic therapy for a variety of psychiatric illnesses.
At the conclusion of this course, participants will be able to:
- Describe the basic pharmacological action of psychedelics drugs
- Analyze the difference between classic psychedelic drugs like LSD and other compounds, like MDMA and ketamine
- Discuss the latest evidence for the therapeutic potential of psychedelics in psychiatry
- Explain when to anticipate the potential FDA approval of treatments such as MDMA-therapy for PTSD and psilocybin-therapy for depression
This CE program is free to Kaiser Permanente employees.
Continuing Education Information
Kaiser Permanente Northern California Mental Health Training Programs is approved by the California Psychological Association, Office of Professional Development, to sponsor continuing professional education for psychologists in California.
Kaiser Permanente Northern California Mental Health Training Programs designate this live activity for 3 hours continuing education credits for the above-identified licensed professionals.
Refund and Attendance Policy
The seminars mentioned above are Free of charge to Kaiser Permanente Employees and Trainees.
IMPORTANT NOTICE: Those who attend the program in full and complete the appropriate evaluation form will receive CE credits. Please note that credit will only be granted for those who attend the entire lecture.